A digital bridge between R&D through manufacturing

Breakthrough treatments, such as mRNA and personalized therapies, have created tremendous opportunities for pharmaceutical companies but require intricate manufacturing, supply chain and quality control processes that are difficult to support. In addition, these complex products are coming to market faster than ever, leaving less time to develop and optimize the manufacturing process.

This combination of product complexity and compressed timeframes highlights the need for a digital thread that can securely connect siloed teams and datasets.

By embracing technologies like Cloud, AI and machine learning, these companies are able to deliver more personalized products faster and improve the patient experience.

AWS and Accenture are collaborating at several pharmaceutical companies to transform these processes. In this session, we identify key learnings and patterns such as how data is being used to optimize clinical trials, accelerate products to market and expand their pipelines to become more patient-centric.


Our Accenture team is here to help

Webinar recording

Customers that innovate with digital thread do so by leveraging the best that the cloud brings. By moving to cloud, our clients are able to migrate applications such as LIMS, MES and quality management systems to free up their IT resources.


Stuart Henderson

Client Account Lead – North America

Dan Sheeran

Healthcare and Life Sciences Director – AWS

Barry Heavey

Managing Director – Life Sciences, Europe

View All
Image Thumbnail

Accenture AWS Business Group (AABG)

Turning innovations rapidly into business value

Accenture + AWS

Platform plays are key enablers for the connected and data driven future in life sciences. The unique business relationship between Accenture and AWS brings you deep technical expertise, extensive AWS experience and breakthrough innovations.

We bring together technology and scalability to move beyond ideas to practical innovations. By working with the Accenture AWS Business Group, you can access the cultures, capabilities and tools of two leading innovators.

In this example, Accenture, AWS and Takeda started thinking outside of the box to think about business challenges and cloud transformation very differently. They called this the Power of Three. And, ultimately, the focus was on Takeda’s patients and how innovation at a rapid speed allowed them to move from treating conditions to keeping people healthy.

Image Thumbnail


Making Organon’s operating model fit for the future
Stay in the know with our newsletter Stay in the know with our newsletter